BofA analyst Allen Lutz raised the firm’s price target on Omnicell (OMCL) to $34 from $30 and keeps a Neutral rating on the shares after the company raised the low end of FY25 EPS and EBITDA guidance to reflect the latest announcement on China tariffs and also announced a $75M share repurchase program. The news is “a clear positive,” but partly already reflected in shares, which have outperformed the S&P 500 index since May 9, the analyst tells investors.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMCL:
- Omnicell price target raised to $37 from $35 at Wells Fargo
- Omnicell’s Enhanced Profitability and Strategic Initiatives Drive Buy Rating with Increased Price Target
- Omnicell Updates 2025 Guidance and Stock Buyback Plan
- Omnicell announces new $75M share repurchase program
- Omnicell narrows FY25 EPS view to $1.30-$1.65 from $1.00-$1.65